Honored for most impactful paper published in 2022

Steenbeek MP, van Bommel MHD, Bulten J, Hulsmann JA, Bogaerts J, Garcia C, Cun HT, Lu KH, van Beekhuizen HJ, Minig L, Gaarenstroom KN, Nobbenhuis M, Krajc M, Rudaitis V, Norquist BM, Swisher EM, Mourits MJE, Massuger LFAG, Hoogerbrugge N, Hermens RPMG, IntHout J, de Hullu JA. Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.

Published in Journal of Clinical Oncology 

(A donation honoring these authors and their contribution has been made to support the Hereditary Breast and Ovarian Cancer Research Group (HEBON) under the Antoni van Leeuwenhoek Foundation)

Prior Honorees

Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, Naveena Singh, Andy Ryan, Chloe Karpinskyj, Giulia Carlino, Julie Taylor, Susan K Massingham, Maria Raikou, Jatinderpal K Kalsi, Robert Woolas, Ranjit Manchanda, Rupali Arora, Laura Casey, Anne Dawnay, Stephen Dobbs, Simon Leeson, Tim Mould, Mourad W Seif, Aarti Sharma, Karin Williamson, Yiling Liu, Lesley Fallowfield, Alistair J McGuire, Stuart Campbell, Steven J Skates, Ian J Jacobs, Mahesh Parmar. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Published in Lancet 2021


Z Hu, M Artibani. A Alsaadi, N Wietek, M Morotti, T Shi, Z Zhong, L Santana Gonzalez, S El-Sahhar, M KaramiNejadRanjbar, G Mallett, Y Feng, K Masuda, Y Zheng, K Chong, S Damato, S Dhar, L Campo, R Garruto Campanile, H Soleymani Majd, V Rai, D Maldonado-Perez, S Jones, V Cerundolo, T Sauka-Spengler, C Yau, and AA Ahmed. The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells.

Published in Cancer Cell. 2020


Dr. Kathleen N. Moore, at the Stephenson Cancer Center of the University of Oklahoma, on behalf of her collaborators for the publication entitled “Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer”, published in the New England Journal of Medicine 2018.


Michael Anglesio, Nikolas Papadopoulus and Ayse Ayhan on behalf of their colleagues for the following publication “Cancer-Associated Mutations in Endometriosis without Cancer”, published in the New England Journal of Medicine 2017.

Ole-Erik Iversen on behalf of his collaborators for the following publication; “Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women”, published in JAMA 2016.

Anne Maree Patch, Elizabeth Christie, Dariush Etemadmoghadam and Dale W Garsed on behalf of their co-authors for the manuscript entitled: ‘Whole-genome characterization of chemoresistant ovarian cancer”, published in Nature 2015.

Dr. Joyce F. Liu,  of  the Dana Farber Cancer Institute, for the paper entitled: “Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study” published in Lancet Oncol 2014.

Nikolaus Dietrich Schultz, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY. For the paper entitled “Integrated genomic characterization of endometrial carcinoma”, published in Nature 2013.

Brooke Winner, MD of Washington University School of Medicine for the paper entitled “Effectiveness of Long-Acting Reversible Contraception”, published in the New England Journal of Medicine in 2012.

Jonathan Ledermann, MD, of the University College London for the paper entitled “Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer” published in the New England Journal of Medicine 2012.

Rebecca L. Stone, MD, of the University of Texas M.D. Anderson Cancer Center for the paper entitled “Paraneoplastic Thrombocytosis in Ovarian Cancer” published in the New England Journal of Medicine 2012.